Deficient Pol γ activity in the skeletal muscle and liver of patients with AHS was first reported by Naviaux et al. in 1999 [11], but POLG mutations were not described until 2001. This evidence concerns the gene POLG and mitochondrial DNA depletion syndrome 4a.